Abstract:The complement system plays a central role in the pathogenesis of Systemic Lupus Erythematosus (SLE), but most studies have focused on the classical pathway. Ficolin-3 is the main initiator of the lectin pathway of complement in humans, but its role in systemic autoimmune disease has not been conclusively determined. Here, we combined biochemical and genetic approaches to assess the contribution of ficolin-3 to SLE risk and disease manifestations. Ficolin-3 activity was measured by a functional assay in serum or plasma samples from Swedish SLE patients (n = 786) and controls matched for age and sex (n = 566). Genetic variants in an extended 300 kb genomic region spanning the FCN3 locus were analyzed for their association with ficolin-3 activity and SLE manifestations in a Swedish multicenter cohort (n = 985). Patients with ficolin-3 activity in the highest tertile showed a strong enrichment in an SLE cluster defined by anti -Sm/DNA/nucleosome antibodies (OR 3.0, p < 0.001) and had increased rates of hematological disease (OR 1.4, p = 0.078) and lymphopenia (OR = 1.6, p = 0.039). Genetic variants associated with low ficolin-3 activity mapped to an extended haplotype in high linkage disequilibrium upstream of the FCN3 gene. Patients carrying the lead genetic variant associated with low ficolin-3 activity had a lower frequency of hematological disease (OR 0.67, p = 0.018) and lymphopenia (OR 0.63, p = 0.031) and fewer autoantibodies (p = 0.0019). Loss-of-function variants in the FCN3 gene were not associated with SLE, but four (0.5 %) SLE patients developed acquired ficolin-3 deficiency where ficolin-3 activity in serum was depleted following diagnosis of SLE. Taken together, our results provide genetic and biochemical evidence that implicate the lectin pathway in hematological SLE manifestations. We also identify lectin pathway activation through ficolin-3 as a factor that contributes to the autoantibody response in SLE.

Emerging role of ficolins in autoimmune diseases

A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile

Low Serum Ficolin-3 Levels Are Associated with Severity and Poor Outcome in Traumatic Brain Injury

A novel take on idiopathic pulmonary fibrosis disease progression: localised autoimmunity

Emerging role of Fli1 in autoimmune diseases

Ficolin-A induces macrophage polarization to a novel pro-inflammatory phenotype distinct from classical M1

The emerging role of epigenetics in human autoimmune disorders

Emerging role of gut microbiota in autoimmune diseases

Gut Microbiota in Systemic Lupus Erythematosus: A Fuse and a Solution

Emerging role of galectin family in inflammatory autoimmune diseases

Mice Deficient in Ficolin, a Lectin Complement Pathway Recognition Molecule, Are Susceptible to Streptococcus pneumoniae Infection

Emerging role of immune cells as drivers of pulmonary fibrosis

Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis

The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes

Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

The role of ficolin as a pattern recognition receptor in antibacterial immunity in Eriocheir sinensis

Current development of Fc gamma receptors (FcγRs) in diagnostics: a review

Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling

Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools

Exploring the role of gut microbiome in autoimmune diseases: A comprehensive review